Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvianolic acid A Tablets in painful diabetic peripheral neuropathy
CTR20210544Phase 2Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of salvianolic acid a in diabetic polyneuropathy (DPN), sponsored by Shanghai Institute of Materia Medica. Started Apr 2021; status: completed.
02
Drugs
salvianolic acid a
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20210544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210544.